Skip to main content

Your search for “drug development” returned 961 results

Researchers Reveal 3D Structure of Cell’s Inflammation Sensor and its Inhibitors

December 7, 2016

…molecules fit together may better enable pharmaceutical companies to develop anti-inflammatory drugs that bind and inhibit CCR2 in a similar manner. The study is published December 7 by Nature.

Pharmaceutical Companies to Share Data for Drug Design via New UC San Diego-Led Resource

October 9, 2014

…unreleased proprietary data for drug discovery through a new $3.7 million effort funded by the National Institutes for Health. The project, which is led by UC San Diego principal investigators Rommie Amaro, Victoria Feher and Dr. Michael K. Gilson, includes a major subcontract to Rutgers University, directed by Dr. Stephen…

Cancer Stem Cells Linked to Drug Resistance

April 20, 2014

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a biomarker called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing…

UC San Diego Launches New Center for Anti-Parasitic Drug Discovery and Development

June 13, 2018

…people globally, yet are rarely the target of new drug discovery efforts. Leveraging its strengths in molecular biology, clinical research and pharmaceutical sciences, the University of California San Diego has now launched a new Center for Anti-Parasitic Drug Discovery and Development to address this unmet need in global health.

Karl Y. Hostetler, MD, Receives Prestigious 2012 Gertrude Elion Memorial Award

April 17, 2012

Karl Y. Hostetler, MD, has been selected as the recipient of the 2012 Gertrude Elion Memorial Lecture Award by the International Society of Antiviral Research. Hostetler is a professor of medicine in the Divisions of Infectious Diseases and Endocrinology at the UC San Diego School of Medicine.

Boosting the Body’s Natural Ability to Fight Urinary Tract Infections

April 30, 2015

…of Pharmacy and Pharmaceutical Sciences report that an experimental drug that stabilizes a protein called HIF-1alpha protects human bladder cells and mice against a major UTI pathogen. The drug might eventually provide a therapeutic alternative or complement to standard antibiotic treatment.

Meet Dr. Brookie Best, Dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences

August 11, 2022

…the effects of anti-HIV drugs in pregnant women, children and non-pregnant adults, and drugs used to treat Kawasaki disease, the leading cause of acquired heart disease in children. She has authored more than 130 peer-reviewed papers, lectured on maternal and pediatric drug therapeutics at the National Institute of Allergy and…

Common Class of Drugs Linked to Increased Risk of Alzheimer’s Disease

September 4, 2020

UC San Diego researchers report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer’s disease.

Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer

November 20, 2018

A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.

A Dose of Research

March 23, 2017

…more about how therapeutic drugs move through the human body,” he said. “But I also like working with patients—something we get to do more and more of in the second half of pharmacy school.” To help find his path, Yang has become the first Skaggs School of Pharmacy student to…

Category navigation with Social links